Buku Lanu Loyamba kwa NLPHL Kuchokera ku Symptoms to Treatment
Nodular lymphocyte kwambiri ya Hodgkin lymphoma (NLPHL) ndi mtundu wa matenda a Hodgkin , khansa ya maselo a maselo . Ndi imodzi mwa mitundu yochepa ya Hodgkin lymphoma , yomwe ili ndi magawo asanu mwa magawo asanu a khansa iyi. Komabe, ili ndi mbali zingapo zosiyana zomwe zimasiyanitsa ndi mitundu ina ya matenda a Hodgkin omwe amatchedwa masikini amodzi a Hodgkin.
Ndani Amalandira Lymphocyte Yodabwitsa Kwambiri ya Hodgkin Lymphoma?
NLPHL ikhoza kuchitika pa msinkhu uliwonse, ngakhale odwala ambiri nthawi zambiri ali ndi zaka zitatu. Amakhala ophatikiza katatu kuposa amuna amodzi poyerekeza ndi mlingo wazimayi. Palibe chifukwa chokhalitsa, koma zifukwa zoopsya zimaphatikizapo kukhala ndi kachilombo ka Epstein-Barr komanso kukhala ndi chiwerengero choyamba cha Hodgkin lympoma.
Kodi Ndi Zizindikiro Ziti za NLPHL?
Chizindikiro chenichenicho cha matendawa ndi kukula kwa maselo a mitsempha m'khosi, pachifuwa kapena pamphuno. Kuphatikizidwa kwa ma lymph nodes kapena ziwalo zina sizodabwitsa. Zizindikiro zina za lymphoma zimakhala ndi malungo, kutaya thupi ndi thukuta usiku. Kuyezetsa thupi, mbiri yachipatala, ndi mayeso a magazi zidzachitika.
Matenda a lymphoma amapangidwa ndi lymph node biopsy . Mtundu weniweni wa lymphoma umatsimikiziridwa ndi mayesero omwe amatha kusiyanitsa pakati pa NLPHL ndi mitundu ina ya Hodgkin lymphoma.
NLPHL imapangidwa ndi B-maselo osokonezeka, omwe nthawi zambiri amakhala mbali ya chitetezo cha mthupi chomwe chimapanga ma antibodies. Amakhala ndi ma antigen a CD, mapuloteni pamwamba pa maselo, omwe amachititsa kuti apeze matendawa pogwiritsa ntchito kafukufuku wamagetsi ndi ma CD. Mankhwalawa apadera a CD antigen amagwiritsidwanso ntchito pa zovuta zowononga mankhwala opatsirana a monoclonal.
Kodi NLPHL Yatengedwa Bwanji?
Pafupifupi odwala 8 mwa khumi alionse omwe ali ndi NLPHL amapezeka kuti ali ndi mapuloteni oyambirira , omwe amaphatikizapo mitsempha ya m'kati mwa thupi ndi pamtunda. NLPHL imayamba kukula pang'onopang'ono kusiyana ndi kalasi ya Hodgkin lymphoma, ndipo ngati mulibe zizindikilo zimatha kuganizira ndi kuyembekezera zizindikiro musanayambe kumwa mankhwala. Ngati lymphoma ili pachiyambi pomwe mulibe zizindikiro za B zingathe kuchiritsidwa ndi mankhwala opatsirana pogwiritsa ntchito mankhwala. Zizindikiro B zimaphatikizapo kutentha thupi, kutaya thupi, ndi kutaya thukuta usiku.
Ngati muli ndi zizindikiro za B kapena vuto lanu likupita patsogolo, ndiye kuti chithandizo cha matenda oopsa kwambiri a Hodgkin lymphoma chimaphatikizapo mankhwala a chemotherapy ndipo nthawi zambiri mankhwalawa amathandizanso. Mankhwala a monoclonal rituximab angaperekedwe Odwala ambiri amamva bwino kwambiri kuchipatala, ndipo oposa 90% amachiritsidwa. Mavuto a matenda a Hodgkin akukula chifukwa cha kupita patsogolo kwa mankhwala.
Ngakhale kuti izi ndizizindikiro zabwino, 10% mpaka 40 peresenti ya odwala omwe amakhala aakulu kwambiri B-cell lymphoma amayamba zaka khumi mutatha kuchiza. Monga NLPHL kawirikawiri imawoneka mwa anyamata, ndikofunika kuti apitirize kutsatiridwa nthawi yaitali kuti azindikire kubwereza. Ngakhale kuti mankhwala awo oyamba angapangitse mankhwala, chizoloŵezi cha kubwereranso ndi kupitako patsogolo kumakhala kofunikira kwambiri moti amafunikira kuyang'aniridwa mosalekeza kwa nthawi yaitali.
Chithandizo cha odwala NLPHL omwe anagwiritsidwa ntchito ndi rituximab, anti-monoclonal antibody, akufufuzidwa.
Zotsatira:
Khansa: Mfundo ndi Zolemba za Oncology 7th Edition. Okonza: VT DeVita, S Hellman ndi SA Rosenberg. Lofalitsidwa ndi Lippincott Williams ndi Wilkins, mu 2005.
> National Cancer Insitu. Mankhwala akuluakulu otchedwa Hodgkin Lymphoma Treatment-kwa akatswiri azaumoyo (PDQ®).
> American Cancer Society. Kuchiza matenda a Hodgkin ochuluka kwambiri (nodular lymphocyte) (NLPHD).